Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Maillinckrodt plc. (NYSE: MNK).

Full DD Report for MNK

You must become a subscriber to view this report.


Recent News from (NYSE: MNK)

Mallinckrodt Plc (MNK) CEO Mark Trudeau Presents at BMO Prescriptions for Success Healthcare Brokers Conference (Transcript)
Mallinckrodt Plc (MNK) BMO Prescriptions for Success Healthcare Conference December 12, 2018, 08:00 AM ET Executives Dan Speciale - IR Mark Trudeau - CEO Steven Romano - EVP & Chief Scientific Officer Hugh O'Neill - EVP & Chief Commercial Officer Analysts Gary Nac...
Source: SeekingAlpha
Date: December, 12 2018 12:22
FDA rejects Mallinckrodt's marketing application for abuse-deterrent oxycodone; shares down 2% premarket
Mallinckrodt (NYSE: MNK ) is down  2%  premarket on light volume following its announcement that subsidiary SpecGx LLC has received a Complete Response Letter (CRL) regarding its marketing application seeking approval for Roxicodone (oxycodone hydrochloride), an abuse-deterrent o...
Source: SeekingAlpha
Date: December, 12 2018 07:09
Mallinckrodt's SpecGx LLC Receives FDA Complete Response Letter for Abuse-Deterrent, Immediate-Release Reformulation of Roxicodone® (Oxycodone Hydrochloride)
STAINES-UPON-THAMES, United Kingdom , Dec. 12, 2018 /PRNewswire/ -- SpecGx LLC, a subsidiary of Mallinckrodt plc (NYSE: MNK) that operates its Specialty Generics business, announced today that it has received a Complete Response Letter from the U.S. Food and Drug Administration (FD...
Source: PR Newswire
Date: December, 12 2018 06:45
Healthcare And Biotechnology Dashboard - Update
This article series provides a monthly dashboard of industries in each sector of the GICS classification. It compares valuation and quality factors relative to their historical averages. Executive summary Biotechnology looks underpriced regarding the historical averages of its valuation ...
Source: SeekingAlpha
Date: December, 11 2018 18:38
Generics under pressure on expanded price-fixing investigation
The broad market's bearishness notwithstanding, generic drug makers are predominantly in the red on the news that the investigation into alleged price-fixing by state AGs now totals 47. More news on: Aceto Corporation, Aclaris Therapeutics, Akorn, Inc., Healthcare stocks news, Stocks on th...
Source: SeekingAlpha
Date: December, 10 2018 12:53
Mallinckrodt plans spin-off of specialty generics business to shareholders
Mallinckrodt (NYSE: MNK ) plans to spin off a new company consisting of it's Specialty Generics/Active Pharmaceutical Ingredients business and AMITIZA (lubiprostone) to shareholders. More news on: Mallinckrodt PLC, Healthcare stocks news, Read more ...
Source: SeekingAlpha
Date: December, 06 2018 07:07
Mallinckrodt Plans Spin-Off of Specialty Generics Business to Shareholders
STAINES-UPON-THAMES, United Kingdom , Dec. 6, 2018 /PRNewswire/ --  Mallinckrodt plc (NYSE: MNK), a leading global specialty pharmaceutical company, today announced plans to spin off a new company consisting of Mallinckrodt's Specialty Generics/Active Pharmaceutical Ingredient...
Source: PR Newswire
Date: December, 06 2018 06:00
Mallinckrodt defends Acthar Gel; shares up a fraction premarket
Reacting to yesterday's Citron Research-stoked  8%  selloff, Mallinckrodt (NYSE: MNK ) issues a statement detailing its commitment to Acthar Gel and the extensive number of clinical trials supporting its efficacy. More news on: Mallinckrodt PLC, Healthcare stocks news, Stocks o...
Source: SeekingAlpha
Date: November, 27 2018 08:58
Mallinckrodt plc (MNK) Investigated by Block & Leviton LLP For Violations of Federal Securities Laws
BOSTON, MA / ACCESSWIRE / November 26, 2018 / Block & Leviton LLP ( www.blockesq.com ), a securities litigation firm representing investors nationwide, is investigating whether Mallinckrodt plc ("Mallinckrodt" or the "Company") (NYSE: MNK) and certain of its officers and directors violat...
Source: ACCESSWIRE IA
Date: November, 26 2018 15:20
Tech Slump Submerges Stocks In Red Sea (Wall Street Breakfast Podcast)
Today's top stories: Tech slump submerges stocks in Red Sea; record breaking number of Americans expected to travel this Thanksgiving; and Bitcoin tumbles 20 percent overnight. If you are interested in listening to Wall Street Breakfast to start your day, look for us in the following ...
Source: SeekingAlpha
Date: November, 20 2018 07:33

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-10-1827.4627.2027.5426.91987,916
2018-10-1727.6827.4427.9127.131,366,149
2018-10-1627.3527.8327.9127.051,167,924
2018-10-1527.3627.1827.9327.071,390,305
2018-10-1226.6627.1627.2426.211,579,518

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-12110,110197,51355.7482Short
2018-12-1138,16373,65451.8139Short
2018-12-1026,730137,87619.3870Cover
2018-12-0769,631239,18229.1121Cover
2018-12-0662,029166,47037.2614Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on MNK.


About Maillinckrodt plc. (NYSE: MNK)

Logo for Maillinckrodt plc. (NYSE: MNK)

Not available

 

Contact Information

     

     

    Current Share Structure

       


      Recent Filings from (NYSE: MNK)

      Report of unscheduled material events or corporate changes.
      Filing Type: 8-KFiling Source: edgar
      Filing Date: August, 07 2018
      Quarterly report with a continuing view of a company's financial position
      Filing Type: 10-QFiling Source: edgar
      Filing Date: August, 07 2018
      Amendment to the SC 13G filing
      Filing Type: SC 13G/AFiling Source: edgar
      Filing Date: July, 10 2018
      Specialized Disclosure Report
      Filing Type: SDFiling Source: edgar
      Filing Date: May, 31 2018
      Report of unscheduled material events or corporate changes.
      Filing Type: 8-KFiling Source: edgar
      Filing Date: May, 17 2018
      Report of unscheduled material events or corporate changes.
      Filing Type: 8-KFiling Source: edgar
      Filing Date: May, 08 2018
      Quarterly report with a continuing view of a company's financial position
      Filing Type: 10-QFiling Source: edgar
      Filing Date: May, 08 2018
      Amendment to a previously filed 8-K
      Filing Type: 8-K/AFiling Source: edgar
      Filing Date: April, 30 2018
      Report of unscheduled material events or corporate changes.
      Filing Type: 8-KFiling Source: edgar
      Filing Date: April, 27 2018
      Official notification to shareholders of matters to be brought to a vote (Proxy)
      Filing Type: DEF 14AFiling Source: edgar
      Filing Date: April, 04 2018

       

       


      Daily Technical Chart for (NYSE: MNK)

      Daily Technical Chart for (NYSE: MNK)


      Stay tuned for daily updates and more on (NYSE: MNK)

      It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

      More to come on (NYSE: MNK)

      Do your DD and if you choose, be ready to go!


       

      The Research: All source information contained in this email is from the public sources mentioned below.

       

       
       

      Thank you

      DD Report
      @DDReports

       

       


      Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in MNK is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of MNK and does not buy, sell, or trade any shares of MNK. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/